Fraser McIntosh

In Vivo Pharmacology, Evotec

Fraser is responsible for global pharmacology across CNS/pain, inflammation, oncology, infectious disease, and cardiometabolic/fibrosis. Prior to joining Evotec in 2015, he was Director of Discovery Services at Charles River Laboratories in Montreal. He has over 25 years of experience in drug discovery and development across different disease areas. Fraser studied pharmacology at Aberdeen University before joining Pfizer in 1990, where he worked on discovery projects in cardiovascular and tissue repair therapy areas.

Repurposing Drugs for Inflammatory Diseases

As history has shown us, let the pathways be the guide.

Feb 21, 2014 |
Fraser McIntosh

Repurposing Drugs for Inflammatory Diseases

What's Hot in 2014: Genetic Testing

The rise and rise of genetic testing as a preventive healthcare measure will become more mainstream and accessible.

Jan 03, 2014 |
Fraser McIntosh

Ouch! The Problem with Those Pain Models

To the dismay of millions of chronic pain sufferers, the search for novel analgesics over the past several decades hasn’t produced much relief. In fact, it’s been one big pain in the…well, you know.

Sep 23, 2013 |
Fraser McIntosh

Ouch! The Problem with Those Pain Models